Related references
Note: Only part of the references are listed.Functional and genetic characterization of three cell lines derived from a single tumor of an Opisthorchis viverrini-associated cholangiocarcinoma patient
Banchob Sripa et al.
HUMAN CELL (2020)
High Glucose Promotes Human Glioblastoma Cell Growth by Increasing the Expression and Function of Chemoattractant and Growth Factor Receptors
Zhiyao Bao et al.
TRANSLATIONAL ONCOLOGY (2019)
STAT3 and STAT5 Activation in Solid Cancers
Sebastian Igelmann et al.
CANCERS (2019)
Overexpression of FoxM1 predicts poor prognosis of intrahepatic cholangiocarcinoma
Lingyun Liu et al.
AGING-US (2018)
Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma
Apinya Jusakul et al.
CANCER DISCOVERY (2017)
High glucose levels boost the aggressiveness of highly metastatic cholangiocarcinoma cells via O-GlcNAcylation
Chatchai Phoomak et al.
SCIENTIFIC REPORTS (2017)
High glucose levels promote the proliferation of breast cancer cells through GTPases
Yilin Hou et al.
BREAST CANCER-TARGETS AND THERAPY (2017)
Targeting hexokinase II as a possible therapy for cholangiocarcinoma
Ubonrat Thamrongwaranggoon et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Cholangiocarcinoma Patient Outcome in Northeastern Thailand: Single-Center Prospective Study
Vor Luvira et al.
Asian Pacific Journal of Cancer Prevention (2016)
Wnt-induced deubiquitination FoxM1 ensures nucleus β-catenin transactivation
Yaohui Chen et al.
EMBO JOURNAL (2016)
FOXM1 and STAT3 interaction confers radioresistance in glioblastoma cells
Uday B. Maachani et al.
ONCOTARGET (2016)
Imaging spectrum of cholangiocarcinoma: role in diagnosis, staging, and posttreatment evaluation
Winnie A. Mar et al.
ABDOMINAL RADIOLOGY (2016)
High glucose enhances progression of cholangiocarcinoma cells via STAT3 activation
Charupong Saengboonmee et al.
SCIENTIFIC REPORTS (2016)
FoxM1 as a Novel Therapeutic Target for Cancer Drug Therapy
Xin-Sen Xu et al.
Asian Pacific Journal of Cancer Prevention (2015)
Diabetes mellitus: Possible risk and promoting factors of cholangiocarcinoma Association of diabetes mellitus and cholangiocarcinoma
Charupong Saengboonmee et al.
CANCER EPIDEMIOLOGY (2015)
FoxM1 Drives a Feed-Forward STAT3-Activation Signaling Loop That Promotes the Self-Renewal and Tumorigenicity of Glioblastoma Stem-like Cells
Ai-hua Gong et al.
CANCER RESEARCH (2015)
Does cancer risk increase with HbA1c, independent of diabetes?
J. C. de Beer et al.
BRITISH JOURNAL OF CANCER (2014)
Different expression of glucose transporters in the progression of intrahepatic cholangiocarcinoma
Yuichiro Kubo et al.
HUMAN PATHOLOGY (2014)
The Role of STAT3 in Non-Small Cell Lung Cancer
Daijiro Harada et al.
CANCERS (2014)
Prognosis of the intrahepatic cholangiocarcinoma after resection: hepatitis B virus infection and adjuvant chemotherapy are favorable prognosis factors
Rui-qing Liu et al.
CANCER CELL INTERNATIONAL (2013)
Forkhead Box M1 Is Regulated by Heat Shock Factor 1 and Promotes Glioma Cells Survival under Heat Shock Stress
Bingbing Dai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
FOX(M1) News-It Is Cancer
Marianna Halasi et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Hyperglycemia is a significant prognostic factor of hepatocellular carcinoma after curative therapy
Takanori Hosokawa et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma
William C. Palmer et al.
JOURNAL OF HEPATOLOGY (2012)
Forkhead Box M1 (FoxM1) Gene Is a New STAT3 Transcriptional Factor Target and Is Essential for Proliferation, Survival and DNA Repair of K562 Cell Line
Andre L. Mencalha et al.
PLOS ONE (2012)
Location, Location, Location: FoxM1 Mediates β-Catenin Nuclear Translocation and Promotes Glioma Tumorigenesis
Angela Bowman et al.
CANCER CELL (2011)
Multiple faces of FoxM1 transcription factor Lessons from transgenic mouse models
Tanya V. Kalin et al.
CELL CYCLE (2011)
High Glucose Promotes Pancreatic Cancer Cell Proliferation via the Induction of EGF Expression and Transactivation of EGFR
Liang Han et al.
PLOS ONE (2011)
Forkhead box M1 transcription factor: A novel target for cancer therapy
Zhiwei Wang et al.
CANCER TREATMENT REVIEWS (2010)
Interleukin-1 Receptor Antagonist Enhances Islet Engraftment Without Impacting Serum Levels of Nitrite or Osteopontin
B. R. Hsu et al.
TRANSPLANTATION PROCEEDINGS (2009)
Clinicopathological and prognostic significance of EGFR, VEGF, and HER2 expression in cholangiocarcinoma
D. Yoshikawa et al.
BRITISH JOURNAL OF CANCER (2008)
Antibody-dependent cellular cytotoxicity of cetuximab against tumor cells with wild-type or mutant epidermal growth factor receptor
Hideharu Kimura et al.
CANCER SCIENCE (2007)
FoxM1: At the crossroads of ageing and cancer
Jamila Laoukili et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2007)
Stattic: A small-molecule inhibitor of STAT3 activation and dimerization
Jochen Schust et al.
CHEMISTRY & BIOLOGY (2006)
FoxM1B is overexpressed in human glioblastomas and critically regulates the tumorigenicity of glioma cells
MG Liu et al.
CANCER RESEARCH (2006)
High glucose transactivates the EGF receptor and up-regulates serum glucocorticoid kinase in the proximal tubule
S Saad et al.
KIDNEY INTERNATIONAL (2005)
Establishment and characterization of an opisthorchiasis-associated cholangiocarcinoma cell line (KKU-100)
Banchob Sripa et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
Genome-wide analysis of gene expression in human intrahepatic cholangiocarcinoma
K Obama et al.
HEPATOLOGY (2005)
Share Paper
